Cam on CaMKII and heart failure research

At the DGK Annual Meeting 2023, Prof. Donald M. Bers, University of California, Davis, reports on his research on the pleitropic enzyme CaMKII, which is involved in various pathological processes in the body. He also talks about possible therapeutic approaches and other research topics he is working on.

Von: Romy Martínez

26.07.2023


Video interview: Heart failure research

with Prof. Donald M. Bers, University of California, Davis, School of Medicine, USA

Related Links

Prof. Mark Anderson, University of Chicago Medical Center, about his research on inhibitors of the protein kinase CaMKII and transatlantic research collaborations.

Link to the online portal of the 89th Annual Meeting

Here you will find the videos of the DGK Annual Meeting 2023.
Access is restricted to DGK members and conference attendees. You don't have a DGK membership yet? Learn more about the benefits of being a DGK member.

Das könnte Sie auch interessieren

TAVI bei Klappeninsuffizienz

London Valves 2025 | ALIGN-AR: Wirksamkeit und Sicherheit einer TAVI-Prothese, die speziell für Aortenklappeninsuffizienz entwickelt wurde. Von Dr. K. Klein.

Wie KI das Elektrokardiogramm neu definiert

ESC Digital & AI Summit 2025 | KI prägt zunehmend EKG-Analyse, Patientensteuerung und Risikomanagement, erläuterte Prof. D. Duncker.

LA-Remodeling mittels KI-basierter EKG-Analyse erkennen

ESC Digital & AI Summit 2025 | ePoster Session: Kann KI linksatriale Dilatation und LVA durch EKG-Auswertung detektieren? PD Dr. S. König berichtet.

Laden, bitte warten.
Diese Seite teilen